Market Research Report
Analyzing Generics Market in France 2017
|Published by||Aruvian's R'search||Product code||549079|
|Published||Content info||95 Pages
|Analyzing Generics Market in France 2017|
|Published: August 1, 2017||Content info: 95 Pages||
The French generic drugs industry has been growing quite well in recent years. While sales of generic drugs took a hit in 2014 as the market was impacted by price cuts, the launch of new generic drugs following many branded drugs going off patents prevented the market from deteriorating too much. The French government has plans to grow the generics market further in the coming years and are putting in place regulations to boost the growth of the industry.
In 2016, the French generics industry crossed revenues of nearly USD 4 billion and it is expected that the industry will continue to grow comfortably to reach a value of USD 5.5 billion by the end of 2021.
Aruvian Research presents Analyzing Generics Market in France 2017 - a comprehensive coverage of the French generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
Moving on, we analyze the Generics Industry in Europe through the same parameters.
The Generics Industry in France is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter's Five Forces analysis of the French Generics Industry. Generics pricing and reimbursement situation in France and trends and challenges facing the industry are analyzed.
Analysis of the major industry players in the French generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Sanofi SA, Les Laboratoires Servier, Teva Pharmaceutical Industries and others.
This research report helps you get an insider's look at the French generic industry and helps you understand what the future holds for the industry. Regulatory framework, pricing and reimbursement scenarios, comparison of the French market with its regional counterparts, all these data points makes this report an essential resource for analytical purposes.